See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2011_Vertex_Pharmaceuticals_INC_MA.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000875320, Vertex Pharmaceuticals INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,057,039,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 26,102,000 |
| 2 | PropertyPlantAndEquipmentNet | 72,333,000 |
| 3 | remainder_Assets | 569,972,000 |
| 4 | LiabilitiesCurrent | 474,783,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 746,690,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 187,800,000 |
| 9 | ResearchAndDevelopmentExpense | 637,416,000 |
| 10 | remainder_Expenses | 33,506,000 |
| 11 | remainder_Revenues | 143,370,000 |
| 12 | remainder_NetIncome | -39,274,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,725,446,000 |
| 1 | Liabilities | 1,221,473,000 |
| 2 | Expenses | 858,722,000 |
| 3 | Revenues | 143,370,000 |
| 4 | StockholdersEquity | 503,973,000 |
| 5 | NetIncome | -754,626,000 |
| 6 | ComprehensiveNetIncome | -754,626,000 |
| 7 | BaseVar | 1,994,142,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.233 |
| 9 | EconomicCapitalRatio | 1.64 |
Edgar->Model Mapping
Feature Distribution
